Standout Papers

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial 2024 202657
  1. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial (2024)
    Egbert F. Smit, Enriqueta Felip et al. The Lancet Oncology

Immediate Impact

5 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Clinical applications of human organoids
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
1 intermediate paper

Works of Ayumi Taguchi being referenced

Establishment and Molecular Phenotyping of Organoids from the Squamocolumnar Junction Region of the Uterine Cervix
2020
Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor
2016

Author Peers

Author Last Decade Papers Cites
Ayumi Taguchi 414 387 496 483 102 1.6k
Andrzej Semczuk 474 475 375 241 125 1.7k
Jacek R. Wilczyński 201 570 493 816 110 1.7k
Soo Young Hur 474 273 424 215 90 2.0k
Dimitrios Haidopoulos 412 504 476 157 121 1.6k
Sandrine Chouzenoux 203 577 776 764 67 1.8k
Yuji Ikeda 437 204 275 327 78 1.3k
Jesús González Bosquet 375 520 512 167 98 1.8k
Feng Xie 278 260 151 387 85 1.5k
H. Kölbl 691 205 221 263 120 2.2k
Janina Markowska 353 151 299 152 124 1.3k

All Works

Loading papers...

Rankless by CCL
2026